Perrigo Company plc (NYSE:PRGO – Get Rating) – Equities research analysts at Jefferies Financial Group issued their Q4 2023 earnings estimates for shares of Perrigo in a research report issued on Monday, May 30th. Jefferies Financial Group analyst S. Wissink forecasts that the company will earn $0.88 per share for the quarter.
Perrigo (NYSE:PRGO – Get Rating) last posted its earnings results on Wednesday, May 11th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by ($0.09). Perrigo had a positive return on equity of 4.88% and a negative net margin of 2.07%. During the same period last year, the business posted $0.50 EPS.
Separately, StockNews.com started coverage on Perrigo in a research report on Thursday, March 31st. They issued a “hold” rating on the stock.
PRGO opened at $39.86 on Wednesday. The stock’s 50-day moving average price is $36.32 and its 200 day moving average price is $37.58. Perrigo has a 12-month low of $31.32 and a 12-month high of $50.90. The company has a current ratio of 4.01, a quick ratio of 2.97 and a debt-to-equity ratio of 0.69. The firm has a market cap of $5.36 billion, a price-to-earnings ratio of -61.32 and a beta of 1.01.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 21st. Shareholders of record on Friday, June 3rd will be given a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date is Thursday, June 2nd. Perrigo’s dividend payout ratio is currently -160.00%.
In other news, EVP Ronald Craig Janish sold 3,954 shares of the stock in a transaction dated Monday, March 7th. The stock was sold at an average price of $36.73, for a total value of $145,230.42. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Thomas Farrington sold 24,485 shares of the stock in a transaction dated Monday, March 14th. The shares were sold at an average price of $37.13, for a total value of $909,128.05. The disclosure for this sale can be found here. 0.80% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Yousif Capital Management LLC acquired a new position in shares of Perrigo in the fourth quarter worth $2,642,000. Millennium Management LLC lifted its stake in shares of Perrigo by 1,723.2% during the third quarter. Millennium Management LLC now owns 1,319,429 shares of the company’s stock worth $62,449,000 after purchasing an additional 1,247,060 shares in the last quarter. Rhumbline Advisers lifted its stake in shares of Perrigo by 3.5% during the fourth quarter. Rhumbline Advisers now owns 341,531 shares of the company’s stock worth $13,286,000 after purchasing an additional 11,453 shares in the last quarter. Morgan Stanley lifted its stake in shares of Perrigo by 38.9% during the third quarter. Morgan Stanley now owns 1,054,813 shares of the company’s stock worth $49,925,000 after purchasing an additional 295,354 shares in the last quarter. Finally, Advisor Group Holdings Inc. lifted its stake in shares of Perrigo by 221.8% in the third quarter. Advisor Group Holdings Inc. now owns 10,936 shares of the company’s stock worth $516,000 after acquiring an additional 7,538 shares in the last quarter. Institutional investors and hedge funds own 91.25% of the company’s stock.
About Perrigo (Get Rating)
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International.
Receive News & Ratings for Perrigo Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Perrigo and related companies with MarketBeat.com’s FREE daily email newsletter.